Navigation Links
Making bacteria make useful proteins
Date:9/6/2009

By adapting a single protein on the surface of the bacterium Caulobacter crescentus, researchers at the University of British Columbia have turned it into a protein production factory, making useful proteins that can act as vaccines and drugs. Dr. John Smit presented the findings at the Society for General Microbiology's meeting at Heriot-Watt University, Edinburgh, today (7 September).

C. crescentus is a harmless bacterium that has a single protein layer on its surface. Dr Smit's team adapted the system that secretes this protein, which self-assembles into a structure called the "S-layer", to secrete instead many proteins that are useful for vaccines and other therapeutic purposes. Or, by keeping the S-layer protein intact and genetically inserting new things inside it, they produce a very dense display of useful proteins on the cell surface and then expect to use the entire bacterium in a therapeutic application.

Bacteria are commonly used in biotechnology to produce useful protein products. If the bacteria secrete the protein rather than keep it contained within the cell, purification costs are greatly lowered. The researchers have developed a commercially available kit based on this technology, which could be especially useful in developing countries as it might be used to manufacture HIV-blocking agents very cheaply and with little specialist expertise.

"This S-layer system is very efficient at producing and secreting proteins we can make the bacterium into a protein pump, secreting over half of all the protein it makes as engineered S-layer protein," said Dr Smit, "Applications of S-layer display that we are currently developing include anti-cancer vaccines, an HIV infection blocker and agents to treat Crohn's and colitis, and diarrhoea in malnourished populations".


'/>"/>

Contact: Dianne Stilwell
diannestilwell@me.com
44-795-720-0214
Society for General Microbiology
Source:Eurekalert

Page: 1

Related biology technology :

1. Analysis of Biofuels Indirect Land Use Effects Finds the Science Lacking: Too Diffuse and Subject To Too Many Arbitrary Assumptions To Be Useful for Rule-making.
2. Bioterrorism and disaster preparedness explored in special issue of Medical Decision Making
3. Brain research shows past experience is invaluable for complex decision making
4. Global Financial Crisis Making Biotech Business Model Unsustainable, According to Ernst & Young
5. Physicists discover important step for making light crystals
6. Patent for Making Combination Chemotherapy Work Better
7. Nanonet circuits closer to making flexible electronics reality
8. Controlling the size of nanoclusters: First step in making new catalysts
9. Making a good impression: Nanoimprint lithography tests at NIST
10. Carrington Subsidiary DelSite Starts Making Test Batches of First Bird Flu Vaccine Offering Needle-free Self-Administration
11. DuPont Chief Science & Technology Officer Offers Perspectives on Science and Global Policymaking at Davos World Economic Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... 23, 2016  The Biodesign Challenge (BDC), a university ... to harness living systems and biotechnology, announced its winning ... New York City . ... showcased projects at MoMA,s Celeste Bartos Theater during the ... MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
Breaking Biology Technology:
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:5/9/2016)... , UAE, May 9, 2016 ... when it comes to expanding freedom for high net ... Even in today,s globally connected world, there is ... conferencing system could ever duplicate sealing your deal with ... obtaining second passports by taking advantage of citizenship via ...
(Date:4/28/2016)... FRANCISCO and BANGALORE, India , ... of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... provider, today announced a global partnership that will ... way to use mobile banking and payment services. ... is a key innovation area for financial services, but it ...
Breaking Biology News(10 mins):